Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome.

Luciana Yamamoto de AlmeidaDiego Antonio Pereira-MartinsAna Sílvia Gouvêa LimaMárcia Sueli BaggioLuisa Corrêa de Araujo KouryAna Paula LangeSarah Cristina BassiPriscila Santos ScheucherEduardo Magalhaes Rego

Published in: BMC cancer (2020)

We demonstrated that the modulation of IL-8 following ATRA treatment may occur regardless of the development of DS and, therefore, does not appear to be a predictive biomarker to monitor the APL-DS.

Keyphrases

liver failure
acute myeloid leukemia
bone marrow
aortic dissection
acute respiratory distress syndrome
replacement therapy